Andrew Herxheimer
- Medical Terminology top 1%
- Toxicology top 1%
- Pharmacovigilance and Adverse Drug Reactions 10
- Pharmacology top 1%
- Pharmaceutical industry and healthcare 16
-
- Pharmaceutical Economics and Policy 14
- Health Systems, Economic Evaluations, Quality of Life 7
-
- Pharmaceutical Practices and Patient Outcomes 12
-
- Pharmaceutical studies and practices 11
-
- Patient-Provider Communication in Healthcare 8
- Health Sciences Research and Education 7
- Co-authors
- Keith J. PetrieSue ZiéblandH. E. de WardenerAlison ChappleN. D. W. LionelYoon K. LokeDeirdre PriceD M Chaput de Saintonge
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Andrew Herxheimer
147 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 181
- Medical Terminology 23
- Toxicology 174
- Pharmacology 362
- Applied Microbiology and Biotechnology 64
- Endocrine and Autonomic Systems 211
Countries citing papers authored by Andrew Herxheimer
This map shows the geographic impact of Andrew Herxheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Herxheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Herxheimer more than expected).
Fields of papers citing papers by Andrew Herxheimer
This network shows the impact of papers produced by Andrew Herxheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Herxheimer. The network helps show where Andrew Herxheimer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Herxheimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 56 | |
| 2 | 2006 | 44 | |
| 3 | A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine | 2004 | 57 |
| 4 | 2003 | 6 | |
| 5 | The contribution of consumers and patients to clinical research. | 1997 | 2 |
| 6 | 1996 | 6 | |
| 7 | 1994 | 12 | |
| 8 | 1994 | 3 | |
| 9 | 1993 | 91 | |
| 10 | 1990 | 39 | |
| 11 | 1985 | 2 | |
| 12 | 1985 | 13 | |
| 13 | 1983 | 2 | |
| 14 | 1982 | 2 | |
| 15 | 1978 | 43 | |
| 16 | 1978 | 11 | |
| 17 | 1975 | 11 | |
| 18 | 1970 | 65 | |
| 19 | 1966 | 123 | |
| 20 | 1958 | 6 |
About Andrew Herxheimer
Andrew Herxheimer is a scholar working on Geriatrics and Gerontology, Toxicology and Pharmacology, having authored 156 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (16 papers), Pharmaceutical Economics and Policy (14 papers), Pharmaceutical Practices and Patient Outcomes (12 papers), Pharmaceutical studies and practices (11 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers), Patient-Provider Communication in Healthcare (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Health Sciences Research and Education (7 papers). The work is most often cited by research in Medical Terminology (23 citations), Toxicology (174 citations) and Pharmacology (362 citations). Andrew Herxheimer has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Keith J. Petrie, Sue Ziébland, H. E. de Wardener, Alison Chapple, N. D. W. Lionel, Yoon K. Loke, Deirdre Price, D M Chaput de Saintonge, Ann McPherson and Charles Medawar. Their work appears in journals such as Nature, The Lancet and The Journal of Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.